Remove IPO Remove Pharmaceutical Remove Securities
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

But it wasn’t all carve outs and concerned investors – even with the headwinds in the industry and beyond, there were still several traditional public M&A deals involving biotechnology or medical device companies, as large pharmaceutical companies continued to have cash to deploy for acquisitions. Let’s dig in.

M&A 40
article thumbnail

Cooley’s 2023 Life Sciences M&A Year in Review: Potent Mix of Creativity and Resilience Spurs Activity Heading Into 2024

Cooley M&A

While the year saw an overall decline in M&A activity (down 17% from 2022) , total pharmaceuticals and life sciences deal value in 2023 increased by approximately 50% compared to 2022. Why did life sciences outperform the market? The last quarter of the year ended with a surge of deal activity.

M&A 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Shareholders vs. Stakeholders - Understanding Corporate Responsibilities

Peak Frameworks

For example, in the 2012 Facebook IPO, common shareholders gained exposure to the tech giant's fortunes, while also securing a say in corporate matters. Types of Shareholders: Common Shareholders : These individuals hold common shares, entitling them to voting rights and dividends.

article thumbnail

Spot Cyber & IT Challenges Through Improved Due Diligence

M&A Leadership Council

Also, I find it’s helpful to remind deal leaders and business sponsors that every organization has a different definition of what is traditionally called IT, for example, core platform, shared services, network, infrastructure, applications, data, security, etc. All businesses need to be digital businesses these days.

IT 52
article thumbnail

Spot Cyber & IT Challenges

M&A Leadership Council

Also, I find it’s helpful to remind deal leaders and business sponsors that every organization has a different definition of what is traditionally called IT, for example, core platform, shared services, network, infrastructure, applications, data, security, etc. All businesses need to be digital businesses these days.

IT 52
article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years. time highs in 2021.

M&A 40